Drug utilization of biologic therapy in Crohn’s disease and ulcerative colitis: a population-based Danish cohort study 2015

Drug utilization of biologic therapy in Crohn’s disease and ulcerative colitis: a population-based Danish cohort study 2015–2020

Published:2023-02-21 Issue:7 Volume:58 Page:726-736
ISSN:0036-5521
Container-title:Scandinavian Journal of Gastroenterology
language:en
Short-container-title:Scandinavian Journal of Gastroenterology

Author:

Jensen Kristoffer Jarlov¹^ORCID,Jensen Camilla Bjørn¹^ORCID,Wennerström Christina²,Burisch Johan³⁴^ORCID,Petersen Janne¹⁵

Affiliation:

1. Copenhagen Phase IV Unit (Phase4CPH), Department of Clinical Pharmacology and Center for Clinical Research and Prevention, Copenhagen University Hospital – Bispebjerg and Frederiksberg, Copenhagen, Denmark

2. Janssen Cilag AB, Solna, Sweden

3. Gastrounit, Medical Division, University Hospital Copenhagen – Amager and Hvidovre, Hvidovre, Denmark

4. Copenhagen Center for Inflammatory Bowel Disease in Children, Adolescents and Adults, University Hospital Copenhagen – Amager and Hvidovre, Denmark

5. Section of Biostatistics, Department of Public Health, University of Copenhagen

Funder

Janssen Cilag A/S

Publisher

Informa UK Limited

Subject

Gastroenterology

Link

https://www.tandfonline.com/doi/pdf/10.1080/00365521.2023.2173988

Reference31 articles.

1. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies

2. Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee

3. Reviewing treatments and outcomes in the evolving landscape of ulcerative colitis

4. The Danish National Patient Registry: a review of content, data quality, and research potential

5. Validation of ulcerative colitis and Crohn’s disease and their phenotypes in the Danish National Patient Registry using a population-based cohort

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA;Pharmaceutics;2024-05-08

2. Comparative Efficacy of Subcutaneous and Intravenous Infliximab and Vedolizumab for Maintenance Treatment of TNF-naive Adult Patients with Inflammatory Bowel Disease: A Systematic Literature Review and Network Meta-analysis;Digestive Diseases and Sciences;2024-03-18

3. Nanomedicine-Mediated Drug Delivery for Potential Treatment of Inflammatory Bowel Disease: A Narrative Review;Nanomedicine;2024-01